Mental Health

First Opinion Rawan Hamadeh

Health workers’ mental health: Addressing the invisible global pandemic

First Opinion Jay Baruch

Trying to quit my job as an ER doctor gave me reasons to stay

Health Tech Katie Palmer

Telehealth startups prescribing ketamine at home are stirring concern

Health Olivia Goldhill

‘Intriguing and sobering’: Enthusiasm over psilocybin’s effect on depression tempered by questions about durability

Biotech Adam Feuerstein

Relmada antidepressant drug fails first of several late-stage clinical trials

Health Usha Lee McFarling

U.S. preventive health group recommends anxiety screening for kids 8 to 18

Hospitals Tara Bannow and Kate Sheridan

Harassment prompts children’s hospitals to strip websites, threatening access to gender-affirming care

In the Lab Meghana Keshavan

Virtual drug screening identifies possible new antidepressants in LSD-like molecules

D.C. Diagnosis Sarah Owermohle

Health funding battles, a nutrition policy overhaul, and two CBD developments

Health Tech Mario Aguilar

Savvier buyers threaten mental health tech’s momentum

Health Eric Boodman

With homicide the leading cause of maternal mortality, new research shows a link to firearms and intimate partner violence

Exclusive Mario Aguilar

Calm’s head of science departs amid a shakeup at meditation app maker

A STAT Investigation Tara Bannow

The private equity firms, like Blackstone and KKR, behind 8 of the biggest names in autism therapy

First Opinion Michael Pollack

Psychedelics researchers and investors should focus on delivering therapy, not drugs

Biotech Adam Feuerstein

Karuna Therapeutics’ schizophrenia drug achieves study goals, heralding new treatment approach

Health Tech Mario Aguilar

Drawing on therapy developed to save soldiers, an app aims to prevent suicide in those at highest risk

First Opinion Christine Bechtel, Lois Frankel and Jennifer Sweeney

Clinician-administrator relationships are ‘on life support.’ Here’s how to heal them

Health Theresa Gaffney

At a 988 call center, volunteers embrace a new number while providing familiar hope

Insurance Tara Bannow

Insurers, courts grapple with how and when to pay for wilderness therapy — a polarizing industry with a sordid past

Biotech Adam Feuerstein

The biotech scorecard for the third quarter: 18 stock-moving events to watch

First Opinion Julie Morita and Donald Schwarz

Youth and gender-affirming care: let’s start with ‘do no harm’

The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy

Biotech Damian Garde

Praxis’ novel antidepressant fails make-or-break trial

First Opinion Susan Hatters Friedman, Renee Sorrentino and Karen B. Rosenbaum

In Depp v. Heard, forensic psychiatry took the stand. Let’s correct the record

Politics Rachel Cohrs

mental health

Most Read

U.S. surgeon general says workplaces are taking a toll on Americans’ mental and physical health

Risk of ‘brain fog’ and other conditions persists up to two years after Covid infection

Parents and clinicians say private equity’s profit fixation is short-changing kids with autism

There’s no autism epidemic. But there is an autism diagnosis epidemic

Largest psilocybin trial finds the psychedelic is effective in treating serious depression

First-of-its-kind study pits psilocybin against a common antidepressant

Long after the fire of a Covid-19 infection, mental and neurological effects can still smolder

‘Traumatic as hell’: Patients describe what it’s like to be restrained in the ER

All Coverage

Health workers’ mental health: Addressing the invisible global pandemic

Trying to quit my job as an ER doctor gave me reasons to stay

Telehealth startups prescribing ketamine at home are stirring concern

‘Intriguing and sobering’: Enthusiasm over psilocybin’s effect on depression tempered by questions about durability

Relmada antidepressant drug fails first of several late-stage clinical trials

U.S. preventive health group recommends anxiety screening for kids 8 to 18

Harassment prompts children’s hospitals to strip websites, threatening access to gender-affirming care

Virtual drug screening identifies possible new antidepressants in LSD-like molecules

Health funding battles, a nutrition policy overhaul, and two CBD developments

Savvier buyers threaten mental health tech’s momentum

With homicide the leading cause of maternal mortality, new research shows a link to firearms and intimate partner violence

Calm’s head of science departs amid a shakeup at meditation app maker

The private equity firms, like Blackstone and KKR, behind 8 of the biggest names in autism therapy

Psychedelics researchers and investors should focus on delivering therapy, not drugs

Karuna Therapeutics’ schizophrenia drug achieves study goals, heralding new treatment approach

Drawing on therapy developed to save soldiers, an app aims to prevent suicide in those at highest risk

Clinician-administrator relationships are ‘on life support.’ Here’s how to heal them

At a 988 call center, volunteers embrace a new number while providing familiar hope

Insurers, courts grapple with how and when to pay for wilderness therapy — a polarizing industry with a sordid past

The biotech scorecard for the third quarter: 18 stock-moving events to watch

Youth and gender-affirming care: let’s start with ‘do no harm’

Listen: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy

Praxis’ novel antidepressant fails make-or-break trial

In Depp v. Heard, forensic psychiatry took the stand. Let’s correct the record

Key Senate panel wants to axe in-person requirement for virtual mental health services

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day